Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD

Respiratory Medicine

Volumn 105, Issue 9, 2011, Pages 1322-1330

  Dransfield, Mark T ^a   Cockcroft, John R ^b   Townsend, Raymond R ^c   Coxson, Harvey O ^d   Sharma, Sanjay S ^e   Rubin, David B ^e   Emmett, Amanda H ^e   Cicale, Michael J ^e   Crater, Glenn D ^e   Martinez, Fernando J ^f  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e GLAXOSMITHKLINE   (United States)

^f UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Aortic pulse wave velocity; Augmentation index; Computed tomography scanning; Emphysema

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL; PLACEBO; TIOTROPIUM BROMIDE;

ADD ON THERAPY; ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ALBUTEROL; ANDROSTADIENES; ARTERIES; BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASES; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SYMPATHOMIMETICS; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 79960450810     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.05.016     Document Type: Article

References (34)

1. D.D. Sin, L. Wu, and S.F.P. Man The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature Chest 127 6 2005 1952 1959
2. C.E. Bolton, and J.R. Cockcroft Lung function and cardiovascular risk: a stiff challenge? Am J Hypertens 23 6 2010 584
3. R.G. Barr, S. Mesia-Vela, J.H.M. Austin, R.C. Basner, B.M. Keller, and A.P. Reeves Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the emphysema and cancer action project (EMCAP) study Am J Respir Crit Care Med 176 12 2007 1200 1207 (Pubitemid 350256473)
4. D.A. McAllister, J.D. Maclay, N.L. Mills, G. Mair, J. Miller, and D. Anderson Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 176 12 2007 1208 1214 (Pubitemid 350256474)
5. E. Swierblewska, D. Hering, T. Kara, K. Kunicka, P. Kruszewski, and L. Bieniaszewski An independent relationship between muscle sympathetic nerve activity and pulse wave velocity in normal humans J Hypertens 28 5 2010 979 984
6. S. Laurent, J. Cockcroft, L. Van Bortel, P. Boutouyrie, C. Giannattasio, D. Hayoz, B. Pannier, C. Vlachopoulos, I. Wilkinson, and H. Struijker-Boudier Expert consensus document on arterial stiffness: methodological issues and clinical applications Eur Heart J 27 21 2006 2588 2605 (Pubitemid 44627304)
7. C. Vlachopoulos, K. Aznaouridis, and C. Stefanadis Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis J Am Coll Cardiol 55 13 2010 1318 1327
8. R. Sabit, C.E. Bolton, P.H. Edwards, R.J. Pettit, W.D. Evans, and C.M. McEniery Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease Am J Respir Crit Care Med 175 12 2007 1259 1265 (Pubitemid 46905751)
9. J.H. Hull, R. Garrod, T.B. Ho, R.K. Knight, J.R. Cockcroft, and D.J. Shale Increased augmentation index in patients with cystic fibrosis Eur Respir J 34 6 2009 1322 1328
10. C.E. Bolton, J.R. Cockcroft, R. Sabit, M. Munnery, C.M. McEniery, and I.B. Wilkinson Lung function in mid-life compared with later life is a stronger predictor of arterial stiffness in men: the caerphilly prospective study Int J Epidemiol 38 3 2009 867 876
11. M.D. Jankowich, T. Taveira, and W. Wu Decreased lung function is associated with increased arterial stiffness as measured by peripheral pulse pressure: data from NHANES III Am J Hypertens 23 6 2010 614 619
12. P.M.A. Calverley, J.A. Anderson, B. Celli, G.T. Ferguson, C. Jenkins, and P.W. Jones Cardiovascular events in patients with COPD: TORCH study results Thorax 65 8 2010 719 725
13. J.A. Wedzicha, P.M.A. Calverley, T.A. Seemungal, G. Hagan, Z. Ansari, and R.A. Stockley The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide Am J Respir Crit Care Med 177 1 2008 19 26
14. T.A. Lee, A.S. Pickard, D.H. Au, B. Bartle, and K.B. Weiss Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease Ann Intern Med 149 6 2008 380 390
15. L. Huiart, P. Ernst, X. Ranouil, and S. Suissa Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD Eur Respir J 25 4 2005 634 639 (Pubitemid 40528755)
16. M. Dawes, P.J. Chowienczyk, and J.M. Ritter Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm Circulation 95 9 1997 2293 2297 (Pubitemid 27191007)
17. K.M. Mäki-Petäjä, F.C. Hall, A.D. Booth, S.M.L. Wallace, and P.W.P. YasminBearcroft Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy Circulation 114 11 2006 1185 1192 (Pubitemid 44386483)
18. H. Pieringer, U. Stuby, S. Hargassner, and G. Biesenbach Treatment with corticosteroids reduces arterial stiffness in patients with polymyalgia rheumatica as measured with pulse wave analysis Ann Rheum Dis 67 2 2008 279 (Pubitemid 351183327)
19. R. Sabit, C.E. Bolton, C. Allanby, J.R. Cockcroft, and D.J. Shale Arterial stiffness is reduced by combination inhaled corticosteroid/long acting beta-2 agonist therapy in patients with COPD Thorax 62 2007 A142
20. D.M. Mannino COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity Chest 121 5 suppl 2002 121S 126S (Pubitemid 34497328)
21. D.D. Sin, and S.F.P. Man Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? the potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 107 11 2003 1514 1519 (Pubitemid 36378490)
22. N.L. Mills, J.J. Miller, A. Anand, S.D. Robinson, G.A. Frazer, and D. Anderson Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk Thorax 63 4 2008 306 311 (Pubitemid 351497941)
23. R. Sabit, C.E. Bolton, A.G. Fraser, J.M. Edwards, P.H. Edwards, and A.A. Ionescu Sub-clinical left and right ventricular dysfunction in patients with COPD Respir Med 104 8 2010 1171 1178
24. J. Kals, P. Kampus, M. Kals, A. Pulges, R. Teesalu, and M. Zilmer Effects of stimulation of nitric oxide synthesis on large artery stiffness in patients with peripheral arterial disease Atherosclerosis 185 2 2006 368 374
25. J.M. Coulson, J.H.F. Rudd, J.M. Duckers, J.I.S. Rees, D.J. Shale, and C.E. Bolton Excessive aortic inflammation in chronic obstructive pulmonary disease: an 18F-FDG PET pilot study J Nucl Med 51 9 2010 1357 1360
26. D.D. Sin, P. Lacy, E. York, and S.F.P. Man Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 170 7 2004 760 765 (Pubitemid 39298991)
27. D.D. Sin, S.F.P. Man, D.D. Marciniuk, G. Ford, M. FitzGerald, and E. Wong The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 177 11 2008 1207 1214 (Pubitemid 351860929)
28. I. Vivodtzev, C. Minet, B. Wuyam, J. Borel, G. Vottero, and D. Monneret Significant improvement in arterial stiffness after endurance training in patients with COPD Chest 137 3 2010 585 592
29. I.A. Orlova, E.Y. Nuraliev, E.B. Yarovaya, and F.T. Ageev Prognostic value of changes in arterial stiffness in men with coronary artery disease Vasc Health Risk Manag 6 2010 1015 1021
30. F. Fantin, A. Mattocks, C.J. Bulpitt, W. Banya, and C. Rajkumar Is augmentation index a good measure of vascular stiffness in the elderly? Age Ageing 36 1 2007 43 48 (Pubitemid 47072032)
31. M.T. Dransfield, and W.C. Bailey Fluticasone propionate/salmeterol for the treatment of chronic-obstructive pulmonary disease Expert Opin Pharmacother 5 8 2004 1815 1826 (Pubitemid 39117724)
32. S. Andreas, S.D. Anker, P.D. Scanlon, and V.K. Somers Neurohumoral activation as a link to systemic manifestations of chronic lung disease Chest 128 5 2005 3618 3624 (Pubitemid 41698701)
33. Vassaux C, Torre-Bouscoulet L, Zeineldine S, Cortopass F, Paz-Díaz H, Celli BR, et al. Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J 32(5):1275-82.
34. R.G. Barr, D.A. Bluemke, F.S. Ahmed, J.J. Carr, P.L. Enright, and E.A. Hoffman Percent emphysema, airflow obstruction, and impaired left ventricular filling N Engl J Med 362 3 2010 217 227